Amkay Products Return on Equity (ROE) History

Amkay Products Ltd Return on Equity

The Amkay Products Ltd Return on Equity is a key financial metric used by investors to evaluate Amkay Products Ltd's valuation, profitability, and overall financial performance. Tracking the Amkay Products Ltd Return on Equity helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Amkay Products Ltd (NSE: , BSE: 544169) is currently trading at ₹62.80, with a market capitalization of ₹543.57M. As a leading company in the Health technology sector and Medical specialties industry, monitoring the Amkay Products Ltd Return on Equity is essential for fundamental analysis.

Amkay Products Ltd Return on Equity Current Value

The current Amkay Products Ltd Return on Equity stands at 19.60.

The Amkay Products Ltd Return on Equity has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.

Amkay Products Ltd Return on Equity Historical Trend

The Amkay Products Ltd Return on Equity has shown the following historical trend:

• 2024: 19.60
• 2023: 30.28
• 2022: 22.82
• 2021: 26.81
• 2020: 0

The decline in Amkay Products Ltd Return on Equity indicates improving financial efficiency or better earnings growth.

What Amkay Products Ltd Return on Equity Indicates for Investors

The Amkay Products Ltd Return on Equity plays a crucial role in understanding the company's financial health and valuation.

ROE indicates how efficiently the company generates returns for shareholders.

Amkay Products Ltd Return on Equity Analysis Summary

The Amkay Products Ltd Return on Equity remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Amkay Products Ltd Return on Equity should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Amkay Products Ltd Return on Equity helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.